I
IconSite Engagement Liaison
Argentinaonsite
Posted today · via Workday
About this role
Site Engagement Liaison (FSP - Sponsor Dedicated) ICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster. As a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers. As a Site Engagement Liaison at ICON, you will foster relationships with clinical trial sites, enhancing site engagement, and contribute to the advancement of innovative treatments and therapies. What You Will Do: You will contribute to clinical research activities, taking responsibility for your deliverables and working collaboratively.…
What we'd score you on
reqspace match rubricFive dimensions, recruiter-grade. Upload your resume and we'll generate a written explanation of where you fit and where the gaps are.
1
Skills match
For this role: gcp, teams
2
Level fit
We check your title trajectory against the seniority signal of the role.
3
Domain experience
Your work in the role's domain matters more than your years total. We weight recent and direct experience.
4
Recency
A skill you used last quarter weighs more than one from five years ago. We grade on recency, not lifetime.
5
Location fit
This role is based in Argentina. We weight your proximity and willingness to relocate.
Score yourself on this role.
Free · no card · written explanation included
Skills in this role
Pulled from the job description. These are the keywords we'll weight when scoring your fit.
gcpteams
More at Icon
- View →Clinical Project Manager (Oncology)Regional United States (PRA)
- View →Site Partner II (Study Start Up - Regulatory Submissions)Colombia, Bogota
- View →Site Partner II (Study Start Up - Regulatory Submissions)Mexico, Mexico City
- View →Clinical Trial AssociateBrazil, Sao Paulo
- View →Research ScientistUS, Cambridge, MA
- View →Site Activation LeadPoland, Warsaw
